Elarcosa, Millet M.
HRN: 14-40-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
AMPICILLIN 1GM (VIAL)
08/15/2023
08/17/2023
IV
2gms
Q6H
PROM
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes